THE LIPOIC ACID-CONTAINING COMPONENTS OF THE 2-OXOACID DEHYDROGENASE COMPLEXES MIMIC TRIFLUOROACETYLATED PROTEINS AND ARE AUTOANTIGENS ASSOCIATED WITH HALOTHANE HEPATITIS

被引:12
作者
FREY, N
CHRISTEN, U
JENO, P
YEAMAN, SJ
SHIMOMURA, Y
KENNA, JG
GANDOLFI, AJ
RANEK, L
GUT, J
机构
[1] UNIV BASEL, BIOCTR, DEPT PHARMACOL, CH-4056 BASEL, SWITZERLAND
[2] UNIV BASEL, BIOCTR, DEPT BIOCHEM, CH-4056 BASEL, SWITZERLAND
[3] UNIV NEWCASTLE UPON TYNE, SCH MED, DEPT BIOCHEM & GENET, NEWCASTLE UPON TYNE NE2 4HH, TYNE & WEAR, ENGLAND
[4] NAGOYA INST TECHNOL, DEPT BIOSCI, SHOWA KU, NAGOYA, AICHI, JAPAN
[5] ST MARYS HOSP, UNIV LONDON IMPERIAL COLL SCI TECHNOL & MED, ST MARYS HOSP, SCH MED, LONDON W2 1PG, ENGLAND
[6] UNIV ARIZONA, HLTH SCI CTR, DEPT ANESTHESIOL, TUCSON, AZ 85724 USA
[7] RIGSHOSP, DEPT MED A, DK-2100 COPENHAGEN, DENMARK
关键词
D O I
10.1021/tx00047a014
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Anti-CF3CO antibodies, monospecific toward trifluoroacetylated proteins (CF3CO-proteins), which are elicited in experimental animals and humans exposed to the anesthetic agent halothane, cross-react with an unknown protein of approximately 52 kDa, constitutively expressed in tissues of experimental animals and humans not previously exposed to the agent. Using anti-CF3CO antibody, the protein(s) of 52 kDa could be immunoprecipitated from solubilized rat heart homogenate. Two-dimensional gel electrophoretic analysis revealed the presence of distinct major (P1, P2) and minor (P3, P4, P5) protein components with apparent molecular masses of 52 kDa. From each of the components P1 and P2, the amino acid sequences of three peptides were determined and found to exhibit 100% identity with the corresponding amino acid sequences of the E2 subunit of the rat 2-oxoglutarate dehydrogenase complex (OGDC). Additionally to the E2 subunit of OGDC, anti-CF3CO antibody also recognized on immunoblots the purified E2 subunit of the branched chain 2-oxoacid dehydrogenase complex (BCOADC) and protein X, a constituent of the pyruvate dehydrogenase complex (PDC), in a manner sensitive to competition by N-6-(trifluoroacetyl)-L-lysine (CF3CO-Lys), 6(RS)-lipoic acid, and N-6-(6(RS)-lipoyl)-L-lysine (lipoyl-Lys). Furthermore, a discrete population of autoantibodies was identified in sera of patients with halothane hepatitis which could not discriminate between the lipoylated target epitope present on the E2 subunit of OGDC and epitopes on CF3CO-RSA, used as model for CF3CO-proteins. These data suggest that the autoantigenicity of these proteins in halothane hepatitis is based on the molecular mimicry of CF3CO-Lys by lipoic acid, the prosthetic group common to protein X and the E2 subunits of OGDC and BCOADC.
引用
收藏
页码:736 / 746
页数:11
相关论文
共 72 条
[21]   THE KIDNEY AS A NOVEL TARGET TISSUE FOR PROTEIN ADDUCT FORMATION ASSOCIATED WITH METABOLISM OF HALOTHANE AND THE CANDIDATE CHLOROFLUOROCARBON REPLACEMENT 2,2-DICHLORO-1,1,1-TRIFLUOROETHANE [J].
HUWYLER, J ;
AESCHLIMANN, D ;
CHRISTEN, U ;
GUT, J .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1992, 207 (01) :229-238
[22]   EXPOSURE TO THE CHLOROFLUOROCARBON SUBSTITUTE 2,2-DICHLORO-1,1,1-TRIFLUOROETHANE AND THE ANESTHETIC AGENT HALOTHANE IS ASSOCIATED WITH TRANSIENT PROTEIN ADDUCT FORMATION IN THE HEART [J].
HUWYLER, J ;
GUT, J .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 184 (03) :1344-1349
[23]   INTERNAL SEQUENCES FROM PROTEINS DIGESTED IN POLYACRYLAMIDE GELS [J].
JENO, P ;
MINI, T ;
MOES, S ;
HINTERMANN, E ;
HORST, M .
ANALYTICAL BIOCHEMISTRY, 1995, 224 (01) :75-82
[24]   T-CELL TOLERANCE BY CLONAL ELIMINATION IN THE THYMUS [J].
KAPPLER, JW ;
ROEHM, N ;
MARRACK, P .
CELL, 1987, 49 (02) :273-280
[25]   SELF-TOLERANCE ELIMINATES T-CELLS SPECIFIC FOR MLS-MODIFIED PRODUCTS OF THE MAJOR HISTOCOMPATIBILITY COMPLEX [J].
KAPPLER, JW ;
STAERZ, U ;
WHITE, J ;
MARRACK, PC .
NATURE, 1988, 332 (6159) :35-40
[26]   SPONTANEOUS LOSS OF T-CELL TOLERANCE TO GLUTAMIC-ACID DECARBOXYLASE IN MURINE INSULIN-DEPENDENT DIABETES [J].
KAUFMAN, DL ;
CLARESALZLER, M ;
TIAN, JD ;
FORSTHUBER, T ;
TING, GSP ;
ROBINSON, P ;
ATKINSON, MA ;
SERCARZ, EE ;
TOBIN, AJ ;
LEHMANN, PV .
NATURE, 1993, 366 (6450) :69-72
[27]  
KENNA JG, 1988, J PHARMACOL EXP THER, V245, P1103
[28]  
KENNA JG, 1990, DRUG METAB DISPOS, V18, P788
[29]   EVIDENCE FOR EXPRESSION IN HUMAN-LIVER OF HALOTHANE-INDUCED NEOANTIGENS RECOGNIZED BY ANTIBODIES IN SERA FROM PATIENTS WITH HALOTHANE HEPATITIS [J].
KENNA, JG ;
NEUBERGER, J ;
WILLIAMS, R .
HEPATOLOGY, 1988, 8 (06) :1635-1641
[30]  
KENNA JG, 1987, J PHARMACOL EXP THER, V242, P733